Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -73.85% is 279% below its 5-year average of -19.48%, near the low end of its 5-year range (-73.85%–-8.09%).
239.54% below its 12-month average of -21.75%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -11.30%.
RETURN ON ASSETS (ROA)
-73.85%
RETURN ON ASSETS (ROA) AVG TTM
-21.75%
RETURN ON ASSETS (ROA) AVG 3Y
-19.65%
RETURN ON ASSETS (ROA) AVG 5Y
-19.48%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-239.54%
CURRENT VS 3Y AVG
-275.87%
CURRENT VS 5Y AVG
-279.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.81%
median of 819 covered companies
CURRENT VS SECTOR MEDIAN
-132.16%
vs the sector median at left
Health Catalyst, Inc.
Market Cap
$132.64M
Return on Assets (ROA)
-73.85%
TTM Avg
-21.75%
3Y Avg
-19.65%
5Y Avg
-19.48%
Market Cap
$133.72M
Return on Assets (ROA)
-35.50%
TTM Avg
-18.07%
3Y Avg
-62.20%
5Y Avg
-134.72%
Market Cap
$133.33M
Return on Assets (ROA)
-6.07%
TTM Avg
-5.08%
3Y Avg
-4.92%
5Y Avg
-1.70%
Market Cap
$134.10M
Return on Assets (ROA)
10.55%
TTM Avg
-7.15%
3Y Avg
-30.40%
5Y Avg
-23.45%
Market Cap
$130.78M
Return on Assets (ROA)
-161.55%
TTM Avg
-68.10%
3Y Avg
-58.95%
5Y Avg
-64.88%
Market Cap
$135.65M
Return on Assets (ROA)
-33.22%
TTM Avg
-27.55%
3Y Avg
-27.55%
5Y Avg
-27.55%
Market Cap
$136.91M
Return on Assets (ROA)
-6.51%
TTM Avg
-15.82%
3Y Avg
-25.09%
5Y Avg
-19.08%
Market Cap
$138.31M
Return on Assets (ROA)
-36.33%
TTM Avg
-27.39%
3Y Avg
-256.74%
5Y Avg
-207.88%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Health Catalyst, Inc. (HCAT) | $132.64M | -73.85% | -21.75% | -19.65% | -19.48% |
| LifeMD, Inc. (LFMD)vs › | $133.72M | -35.50% | -18.07% | -62.20% | -134.72% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $133.33M | -6.07% | -5.08% | -4.92% | -1.70% |
| Organigram Global Inc. (OGI)vs › | $134.10M | 10.55% | -7.15% | -30.40% | -23.45% |
| Pyxis Oncology, Inc. (PYXS)vs › | $130.78M | -161.55% | -68.10% | -58.95% | -64.88% |
| Freenome, Inc. (FRNM)vs › | $135.08M | N/A | N/A | N/A | N/A |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.65M | -33.22% | -27.55% | -27.55% | -27.55% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.91M | -6.51% | -15.82% | -25.09% | -19.08% |
| Alpha Cognition Inc (ACOG)vs › | $138.31M | -36.33% | -27.39% | -256.74% | -207.88% |
| Entera Bio Ltd. (ENTX)vs › | $126.51M | -87.44% | -86.57% | -87.06% | -85.09% |
ROA
-73.8%
ROE
-262.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -35.41% |
| 2024-12-31 | -8.09% |
| 2023-12-31 | -16.83% |
| 2022-12-31 | -18.26% |
| 2021-12-31 | -18.41% |
| 2020-12-31 | -19.91% |
| 2019-12-31 | -19.88% |
| 2018-12-31 | -55.85% |
| 2017-12-31 | -42.66% |
